Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
June 28, 2007

QGC Forms Partnership with French Organizations Related to Drug Development for Cardiovascular Diseases

  • Quantum Genomics (QGC), Inserm, CNRS, and the University Paris Descartes are collaborating to develop drugs for hypertension and related cardiovascular diseases.

    The first compound, QGC001, to be pursued will be a candidate from discoveries by teams led by Catherine Llorens-Cortes, director of Inserm Unit 691, and Bernard P. Roques at Inserm Unit 640, based in the University of Paris Descartes. QGC expects to start a clinical trial in 2008.

    Under the terms of the contract, QGC acquires rights to exploit three patents and associated know-how. Inserm and CNRS will work on the physiopathology, chemistry, and understanding of the compound's mechanism of action, whereas QGC will handle preclinical and clinical development and regulatory aspects.

  • You’re all set! Thank you for subscribing to GEN Highlights.